Spray

ReCell Receives FDA Approval for Clinical Trial

Avita Medical has received approval from the US Food and Drug Administration (FDA) to begin its US clinical trial for ReCell Spray-On Skin, a stand-alone regenerative point-of-care device enabling surgeons to treat burns, wounds and chronic skin defe…

Spray | 25 December 2009

• Avita
• FDA
• trial
• ReCell
• Spray

Novartis Launches Nasal Spray in India

Novartis India has launched Otrivin in a nasal spray format. The drug will now be available as a topical nasal decongestant in an easy-to-use direct acting spray format. The nasal nasal spray will be available over-the-counter (OTC) at chemiststores.…

Spray | 08 September 2009

• Novartis
• India
• Otrivin
• nasal
• spray

BioAlliance acquires European Rights for Ondansetron Oral Spray

BioAlliance Pharma SA a specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, has announced that it has acquired the European commercial rights to ondansetron Oral Spray (OS) from NovaDel Pharma Inc.…

Spray | 21 May 2008

Australia's Acrux Menopause Spray Sees Results In US Phase III Trial

Australia-based pharmaceutical company with unique technology for delivering drugs through the skin, Acrux, has announced positive results in a US Phase III clinical trial of Evamist, its daily skin spray for prevention of symptoms associated with me…

Spray | 26 July 2007

Spray-Dry Vaccine for TB Developed

Bioengineers and public health researchers at the Harvard University School of Engineering and Applied Sciences (SEAS), and School of Public Health have developed a novel spray-drying method for preserving and delivering the most common tuberculosis…

Spray | 01 March 2007